Orgenesis Inc. announced that Professor Itamar Raz has been appointed to the Orgenesis Board of Advisors. Prof. Raz has been involved in a number of organizations focused on diabetes, as well as in other medical associations. Currently, Itamar Raz is a Professor of Medicine and Head of the Diabetes Unit at the Hadassah Ein Kerem Hospital in Jerusalem.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4717 USD | +2.50% | -1.75% | -5.79% |
20/05 | Orgenesis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
16/04 | North American Morning Briefing : Powell Comments, -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
-5.79% | 15.69M | |
-7.77% | 177B | |
-1.33% | 108B | |
-7.54% | 65.55B | |
+3.38% | 50.66B | |
+5.38% | 42.58B | |
+5.73% | 40.74B | |
+17.59% | 31.07B | |
+16.57% | 25.45B | |
-4.30% | 23.93B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc Appoints Itamar Raz as Member of Board of Advisors